Literature DB >> 16734388

VEGF scaffolds enhance angiogenesis and bone regeneration in irradiated osseous defects.

Darnell Kaigler1, Zhuo Wang, Kim Horger, David J Mooney, Paul H Krebsbach.   

Abstract

UNLABELLED: Bone regeneration is challenging in sites where the blood supply has been compromised by radiation. We examined the potential of a growth factor (VEGF) delivery system to enhance angiogenesis and bone formation in irradiated calvarial defects. VEGF-releasing polymers significantly increased blood vessel density and vascular perfusion in irradiated defects and increased bone formation relative to control conditions.
INTRODUCTION: Radiation therapy causes damage to tissues and inhibits its regenerative capacity. Tissue injury from radiation is in large part caused by a compromised vascular supply and reduced perfusion of tissues. The aim of this study was to determine if delivery of vascular endothelial growth factor (VEGF) from a biodegradable PLGA (copolymer of D,L-lactide and glycolide) scaffold could enhance neovascularization and bone regeneration in irradiated osseous defects.
MATERIALS AND METHODS: An isolated area of the calvarium of Fisher rats was irradiated (12 Gy) 2 weeks preoperatively, and two 3.5-mm osseous defects were created in this area, followed by the placement of PLGA scaffolds or VEGF scaffolds (PLGA scaffolds with incorporated VEGF) into the defects. Laser Doppler perfusion imaging was performed to measure perfusion of these areas at 1, 2, and 6 weeks. Implants were retrieved at 2, 6, and 12 weeks, and histologic and muCT analyses were performed to determine neovascularization and bone regeneration.
RESULTS: Histological analyses revealed statistically significant increases in blood vessel formation (>2-fold) and function (30%) within the VEGF scaffolds compared with PLGA scaffolds. Additionally, evaluation of bone regeneration through bone histomorphometric and muCT analyses revealed significantly greater bone coverage (26.36 +/- 6.91% versus 7.05 +/- 2.09% [SD]) and increased BMD (130.80 +/- 58.05 versus 71.28 +/- 42.94 mg/cm(3)) in VEGF scaffolds compared with PLGA scaffolds.
CONCLUSIONS: Our findings show that VEGF scaffolds have the ability to enhance neovascularization and bone regeneration in irradiated osseous defects, outlining a novel approach for engineering tissues in hypovascular environments.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16734388     DOI: 10.1359/jbmr.060120

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  85 in total

1.  Guided bone regeneration using injectable vascular endothelial growth factor delivery gel.

Authors:  Darnell Kaigler; Eduardo A Silva; David J Mooney
Journal:  J Periodontol       Date:  2012-06-05       Impact factor: 6.993

2.  Vascular endothelial growth factor and fibroblast growth factor 2 delivery from spinal cord bridges to enhance angiogenesis following injury.

Authors:  Laura De Laporte; Anne des Rieux; Hannah M Tuinstra; Marina L Zelivyanskaya; Nora M De Clerck; Andrei A Postnov; Véronique Préat; Lonnie D Shea
Journal:  J Biomed Mater Res A       Date:  2011-05-31       Impact factor: 4.396

3.  Bone grafts in craniofacial surgery.

Authors:  Mohammed E Elsalanty; David G Genecov
Journal:  Craniomaxillofac Trauma Reconstr       Date:  2009-10

Review 4.  Strategies for controlled delivery of growth factors and cells for bone regeneration.

Authors:  Tiffany N Vo; F Kurtis Kasper; Antonios G Mikos
Journal:  Adv Drug Deliv Rev       Date:  2012-02-04       Impact factor: 15.470

5.  A modular approach to cardiac tissue engineering.

Authors:  Brendan M Leung; Michael V Sefton
Journal:  Tissue Eng Part A       Date:  2010-10       Impact factor: 3.845

6.  Mechanical and Vascular Cues Synergistically Enhance Osteogenesis in Human Mesenchymal Stem Cells.

Authors:  Andrew J Steward; Jacqueline H Cole; Frances S Ligler; Elizabeth G Loboa
Journal:  Tissue Eng Part A       Date:  2016-07-29       Impact factor: 3.845

7.  Improved growth factor directed vascularization into fibrin constructs through inclusion of additional extracellular molecules.

Authors:  J D Smith; M E Melhem; K T Magge; A S Waggoner; P G Campbell
Journal:  Microvasc Res       Date:  2007-01-16       Impact factor: 3.514

8.  Immobilization of glycoproteins, such as VEGF, on biodegradable substrates.

Authors:  J L Sharon; D A Puleo
Journal:  Acta Biomater       Date:  2008-03-05       Impact factor: 8.947

9.  Multifunctional silk-heparin biomaterials for vascular tissue engineering applications.

Authors:  F Philipp Seib; Manuela Herklotz; Kelly A Burke; Manfred F Maitz; Carsten Werner; David L Kaplan
Journal:  Biomaterials       Date:  2013-10-04       Impact factor: 12.479

10.  Bone regeneration in defects compromised by radiotherapy.

Authors:  W-W Hu; B B Ward; Z Wang; P H Krebsbach
Journal:  J Dent Res       Date:  2010-01       Impact factor: 6.116

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.